Search Orphan Drug Designations and Approvals
-
Generic Name: | 2?(3,5?dichloro?4?([4?hydroxy?3?(propan?2?yl)phenyl]methyl)phenoxy)?N?methylacetamide |
---|---|
Date Designated: | 07/22/2021 |
Orphan Designation: | Treatment of X-linked Adrenoleukodystrophy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Autobahn Therapeutics, Inc. 9880 Campus Point Drive Suite 370 San Diego, California 92121 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-